Evidence map›Paper›PMID 33833531›Full record

ReviewJournal of asthma and allergy2021

New Perspectives in the Management of Mild to Moderate Asthma in Children.

Hacer Ilbilge Ertoy Karagol, Arzu Bakirtas

Abstract readReview
In one paragraph

Review in Journal of asthma and allergy, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Hacer Ilbilge Ertoy KaragolDepartment of Pediatric Allergy and Asthma, Gazi University School of Medicine, Ankara, Turkey.ORCID 0000-0002-8190-062X
Arzu BakirtasDepartment of Pediatric Allergy and Asthma, Gazi University School of Medicine, Ankara, Turkey.ORCID 0000-0002-7694-8944

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mild to moderate asthma makes up the greatest proportion of all asthma severities in childhood. Children who are treated with steps 1-2 are defined as having mild asthma and step 3 as having moderate asthma, according to the guidelines. Although many studies focused on the management of severe asthma over the last decade, there have also been important changes and improvements in the management of mild to moderate asthma. In this article, new perspectives in the management of children with mild to moderate asthma will be reviewed and compared according to the two major guidelines.

Indexed as

asthmalong-acting inhaled bronchodilatorsmildmoderatetreatment

Identifiers

PMID33833531
PMCPMC8020053

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.